Keros Therapeutics (KROS) Asset Utilization Ratio (2020 - 2025)

Keros Therapeutics' Asset Utilization Ratio history runs 6 years deep, the most recent figure standing at 0.45 for Q4 2025.

• Quarterly Asset Utilization Ratio rose 7571.88% year-over-year to 0.45 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.45 (up 7571.88% YoY) and the FY2025 annual result came in at 0.51, up 6999.88% from the prior year.
• Asset Utilization Ratio was 0.45 for Q4 2025 at Keros Therapeutics, up from 0.33 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.45 in Q4 2025 and bottomed at 0.0 in Q3 2023.
• A 5-year average of 0.12 and a median of 0.06 in 2022 frame the typical range for Asset Utilization Ratio.
• Annual changes were most pronounced in 2023 — Asset Utilization Ratio slumped 99.98% — and 2025, when it jumped 60623.7%.
• Keros Therapeutics' Asset Utilization Ratio stood at 0.07 in 2021, then dropped by 13.25% to 0.06 in 2022, then plunged by 99.33% to 0.0 in 2023, then surged by 1255.36% to 0.01 in 2024, then soared by 7571.88% to 0.45 in 2025.
• Business Quant data shows KROS's Asset Utilization Ratio at 0.45 in Q4 2025, 0.33 in Q3 2025, and 0.3 in Q2 2025.